Dr. Steven C Richards, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2811 Tieton Dr, Yakima, WA 98902 Phone: 509-249-5210 |
Paul A Wardrop, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5109 Summitview Ave, Yakima, WA 98908 Phone: 509-907-6300 |
Mr. Michal Jerzy Galeziok, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2811 Tieton Dr, Yakima, WA 98902 Phone: 509-249-5210 |
Brent L Herr, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1806 W Lincoln Ave, Yakima, WA 98902 Phone: 509-452-4520 Fax: 509-452-5224 |
News Archive
Fluidigm Corporation today introduced its 192.24 Dynamic Array™ IFC, designed to genotype 192 samples against 24 SNP assays in a single run, providing 4,608 data points in just one hour. The 192.24 integrated fluidic circuit (IFC) has immediate applicability in agricultural biotechnology and genome wide association studies.
Stallergenes has been granted European approval to market Oralair(R) in both adults and children through a Mutual Recognition Procedure. Germany, the first country where Oralair(R) has been marketed, was the reference Member state.
Nomir Medical Technologies, a leader in the development of optical energy technologies for medical applications, announced today the publication of a scientific paper in the journal Photochemistry and Photobiology that details in vitro and human data demonstrating the unique and patented mechanism-of-action for its Noveon® dual-wavelength device, as well as positive efficacy and safety data.
Atrium Medical Corporation announced that the 1st patient was enrolled in the INFUSE AMI trial. INFUSE AMI is a multi-center, multi-national, prospective, randomized, single blind trial examining how patients with heart attacks are treated. The study's aim is to help determine the best way to treat patients with an acute anterior wall myocardial infarction (acute MI) with ST segment elevation, commonly referred to as STEMIs.
› Verified 4 days ago